Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 777-784

  Paruthiyil, Sreenivasan ^a,c   Cvoro, Aleksandra ^a   Tagliaferri, Mary ^c   Cohen, Isaac ^c   Shtivelman, Emma ^c   Leitman, Dale C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Bionovo Inc   (United States)

Author keywords

Breast cancer; BTG2; Cell cycle; Estrogen receptor; GADD45A; Gene expression; MCF 7 cells

Indexed keywords

CELL PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; ESTROGEN RECEPTOR BETA; PROTEIN C JUN; PROTEIN NCOA2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BTG2 GENE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; ENZYME INHIBITION; GADD45A GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN B1; ESTROGEN RECEPTOR BETA; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; GENES, JUN; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 80052572689     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1273-5     Document Type: Article

References (39)

1. S Sommer SA Fuqua 2001 Estrogen receptor and breast cancer Semin Cancer Biol 11 5 339 352 11562176 10.1006/scbi.2001.0389 1:CAS:528:DC%2BD3MXmvVGgtro%3D (Pubitemid 33016029)
2. V Speirs R Walker 2007 New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast J Pathol 211 499 506 17236182 10.1002/path.2130 1:CAS:528:DC%2BD2sXltFOqur0%3D (Pubitemid 46502425)
3. RR Patel CG Sharma VC Jordan 2007 Optimizing the antihormonal treatment and prevention of breast cancer Breast Cancer (Tokyo, Japan) 14 2 113 122
4. S Paruthiyil H Parmar V Kerekatte GR Cunha GL Firestone DC Leitman 2004 Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res 64 1 423 428 14729654 10.1158/0008-5472.CAN-03-2446 1:CAS:528:DC%2BD2cXkslyqtw%3D%3D (Pubitemid 38114127)
5. A Strom J Hartman JS Foster S Kietz J Wimalasena JA Gustafsson 2004 Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D Proc Natl Acad Sci USA 101 6 1566 1571 14745018 10.1073/pnas.0308319100 (Pubitemid 38236167)
6. G Lazennec D Bresson A Lucas C Chauveau F Vignon 2001 ER beta inhibits proliferation and invasion of breast cancer cells Endocrinology 142 9 4120 4130 11517191 10.1210/en.142.9.4120 1:CAS:528:DC%2BD3MXmsFSgsbY%3D (Pubitemid 32802685)
7. DL Crandall DE Busler TJ Novak RV Weber JG Kral 1998 Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue Biochem Biophys Res Commun 248 3 523 526 9703958 10.1006/bbrc.1998.8997 1:CAS:528:DyaK1cXlt1arsbo%3D (Pubitemid 28404453)
8. EA Vladusic AE Hornby FK Guerra-Vladusic R Lupu 1998 Expression of estrogen receptor beta messenger RNA variant in breast cancer Cancer Res 58 2 210 214 9443393 1:CAS:528:DyaK1cXntFyltw%3D%3D (Pubitemid 28047055)
9. SA Fuqua R Schiff I Parra WE Friedrichs JL Su DD McKee K Slentz-Kesler LB Moore TM Willson JT Moore 1999 Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer Cancer Res 59 21 5425 5428 10554010 1:CAS:528:DyaK1MXnt1Gjtbc%3D (Pubitemid 29526449)
10. PJ Carder CE Murphy P Dervan M Kennedy A McCann PT Saunders AM Shaaban CS Foster CJ Witton JM Bartlett, et al. 2005 A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue Breast Cancer Res Treat 92 3 287 293 16155800 10.1007/s10549-004-4262-8 (Pubitemid 41279638)
11. C Zhao EW Lam A Sunters E Enmark MT De Bella RC Coombes JA Gustafsson K Dahlman-Wright 2003 Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 48 7600 7606 14576822 10.1038/sj.onc.1207100 1:CAS:528:DC%2BD3sXotlais78%3D (Pubitemid 37464093)
12. A Rody U Holtrich C Solbach K Kourtis G von Minckwitz K Engels S Kissler R Gatje T Karn M Kaufmann 2005 Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions Endocr Relat Cancer 12 4 903 916 16322330 10.1677/erc.1.01088 1:CAS:528:DC%2BD28XnvVyjuw%3D%3D (Pubitemid 41815784)
13. CY Lin A Strom S Li Kong S Kietz JS Thomsen JB Tee VB Vega LD Miller J Smeds J Smeds J Bergh, et al. 2007 Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer Breast Cancer Res 9 2 R25 17428314 10.1186/bcr1667 (Pubitemid 350215162)
14. N Honma R Horii T Iwase S Saji M Younes K Takubo M Matsuura Y Ito F Akiyama G Sakamoto 2008 Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy J Clin Oncol 26 22 3727 3734 18669459 10.1200/JCO.2007.14.2968
15. L Nakopoulou AC Lazaris EG Panayotopoulou I Giannopoulou N Givalos S Markaki A Keramopoulos 2004 The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer J Clin Pathol 57 5 523 528 15113861 10.1136/jcp.2003.008599 1:CAS:528:DC%2BD2cXmtl2qurc%3D (Pubitemid 38655949)
16. A Satyanarayana P Kaldis 2009 Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms Oncogene 28 33 2925 2939 19561645 10.1038/onc.2009.170 1:CAS:528:DC%2BD1MXnslOjtrw%3D
17. K Riabowol G Draetta L Brizuela D Vandre D Beach 1989 The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells Cell 57 3 393 401 2541912 10.1016/0092-8674(89)90914-8 1:CAS:528:DyaL1MXkvFCnu70%3D (Pubitemid 19126273)
18. AJ Fornace Jr DW Nebert MC Hollander JD Luethy M Papathanasiou J Fargnoli NJ Holbrook 1989 Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents Mol Cell Biol 9 10 4196 4203 2573827 1:CAS:528:DyaK3cXitlSmtb4%3D (Pubitemid 19239587)
19. M Vairapandi AG Balliet B Hoffman DA Liebermann 2002 GADD45b and GADD45g are cdc2/cyclin B1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress J Cell Physiol 192 3 327 338 12124778 10.1002/jcp.10140 1:CAS:528:DC%2BD38XlvFertbY%3D (Pubitemid 34827609)
20. A Cretu X Sha J Tront B Hoffman DA Liebermann 2009 Stress sensor Gadd45 genes as therapeutic targets in cancer Cancer Ther 7 A 268 276 19652693 1:CAS:528:DC%2BD1MXot1Snur0%3D
21. GS Winkler 2009 The mammalian anti-proliferative BTG/Tob protein family J Cell Physiol 222 1 66 72 10.1002/jcp.21919
22. A Hwang A Maity WG McKenna RJ Muschel 1995 Cell cycle-dependent regulation of the cyclin B1 promoter J Biol Chem 270 47 28419 28424 7499347 10.1074/jbc.270.47.28419 1:CAS:528:DyaK2MXps1ahtLs%3D
23. A Hwang WG McKenna RJ Muschel 1998 Cell cycle-dependent usage of transcriptional start sites. A novel mechanism for regulation of cyclin B1 J Biol Chem 273 47 31505 31509 9813064 10.1074/jbc.273.47.31505 1:CAS:528:DyaK1cXns1ensLk%3D (Pubitemid 28533172)
24. S Jin MJ Antinore FD Lung X Dong H Zhao F Fan AB Colchagie P Blanck PP Roller AJ Fornace Jr, et al. 2000 The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression J Biol Chem 275 22 16602 16608 10747892 10.1074/jbc.M000284200 1:CAS:528:DC%2BD3cXjvFCntbc%3D (Pubitemid 30398886)
25. MS Ryu MS Lee JW Hong TR Hahn E Moon IK Lim 2004 TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression Exp Cell Res 299 1 159 170 15302583 10.1016/j.yexcr.2004.05.014 1:CAS:528:DC%2BD2cXmsVKgu78%3D (Pubitemid 39078391)
26. JP Rouault N Falette F Guehenneux C Guillot R Rimokh Q Wang C Berthet C Moyret-Lalle P Savatier B Pain, et al. 1996 Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway Nat Genet 14 4 482 486 8944033 10.1038/ng1296-482 1:CAS:528: DyaK28XntlGnt74%3D (Pubitemid 26414597)
27. H Kawakubo JL Carey E Brachtel V Gupta JE Green PD Walden S Maheswaran 2004 Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer Oncogene 23 50 8310 8319 15378000 10.1038/sj.onc.1208008 1:CAS:528:DC%2BD2cXovFOgsr8%3D (Pubitemid 39531842)
28. A Cvoro C Tzagarakis-Foster D Tatomer S Paruthiyil MS Fox DC Leitman 2006 Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression Mol Cell 21 4 555 564 16483936 10.1016/j.molcel.2006.01.014 1:CAS:528:DC%2BD28XisVansbk%3D (Pubitemid 43228010)
29. S Karmakar EA Foster CL Smith 2009 Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor Int J Cancer 124 8 1841 1851 19117054 10.1002/ijc.24133 1:CAS:528: DC%2BD1MXjslSms7s%3D
30. JG Jackson OM Pereira-Smith 2006 p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts Cancer Res 66 17 8356 8360 16951143 10.1158/0008-5472.CAN-06-1752 1:CAS:528:DC%2BD28XovF2jurY%3D (Pubitemid 44449144)
31. Q Zhan MJ Antinore XW Wang F Carrier ML Smith CC Harris AJ Fornace Jr 1999 Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 Oncogene 18 18 2892 2900 10362260 10.1038/sj.onc.1202667 1:CAS:528:DyaK1MXjsVyktLg%3D (Pubitemid 29250879)
32. PJ Mitchell R Tjian 1989 Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins Science 245 4916 371 378 2667136 10.1126/science.2667136 1:CAS:528:DyaL1MXltFWjtb4%3D (Pubitemid 19203358)
33. JJ Voegel MJ Heine C Zechel P Chambon H Gronemeyer 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors EMBO J 15 14 3667 3675 8670870 1:CAS:528:DyaK28Xksl2mur4%3D (Pubitemid 26239779)
34. H Hong K Kohli A Trivedi DL Johnson MR Stallcup 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors Proc Natl Acad Sci USA 93 10 4948 4952 8643509 10.1073/pnas.93.10.4948 1:CAS:528:DyaK28XjtVKlt7s%3D (Pubitemid 26163504)
35. T Hunter 1995 Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling Cell 80 2 225 236 7834742 10.1016/0092-8674(95)90405-0 1:CAS:528:DyaK2MXjtlGnsrs%3D
36. SJ Elledge J Winston JW Harper 1996 A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis Trends Cell Biol 6 10 388 392 15157521 10.1016/0962-8924(96)10030-1 1:CAS:528:DyaK28XmsFWgtbg%3D (Pubitemid 26315903)
37. W Wang G Huper Y Guo SK Murphy JA Olson Jr JR Marks 2005 Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer Oncogene 24 16 2705 2714 15735726 10.1038/sj.onc.1208464 1:CAS:528:DC%2BD2MXjtFOku7g%3D (Pubitemid 40593098)
38. PJ Kushner DA Agard GL Greene TS Scanlan AK Shiau RM Uht P Webb 2000 Estrogen receptor pathways to AP-1 J Steroid Biochem Mol Biol 74 5 311 317 11162939 10.1016/S0960-0760(00)00108-4 1:CAS:528:DC%2BD3MXitFyjsg%3D%3D (Pubitemid 32126243)
39. JS Carroll CA Meyer J Song W Li TR Geistlinger J Eeckhoute AS Brodsky EK Keeton KC Fertuck GF Hall, et al. 2006 Genome-wide analysis of estrogen receptor binding sites Nat Genet 38 11 1289 1297 17013392 10.1038/ng1901 1:CAS:528:DC%2BD28XhtFeisbjI (Pubitemid 44646291)